Criterium has recently concluded major gastroenterological studies in the following therapeutic indications:
With Offices in the USA, Canada, South Africa, India, Russia, Israel and Europe, we are poised to take advantage of our access to large patient populations for trials developing new therapies for Gastric Ulcer, Gastric Cancers, Traveler's Diarrhea and other gastroenterological areas.
For NECs, generics, reformulations and new indication approvals, our multi-lingual staff of experts uses state-of-the-art technologies to conduct clinical trials in a time-efficient manner and deliver them at reasonable cost.
For more information contact Ronny Schnel:
Phone: (+ 1) 310-377-7517